Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,275 | -53,981 | -41,226 | -321,545 | -261,281 |
| Depreciation Amortization | 42,606 | 26,818 | 12,802 | 40,745 | 31,464 |
| Accounts receivable | -55,641 | -11,486 | -7,204 | -6,001 | -4,017 |
| Accounts payable and accrued liabilities | -6,332 | -5,223 | -8,305 | -17,563 | -18,573 |
| Other Working Capital | -66,663 | -29,331 | -23,693 | -63,020 | -70,421 |
| Other Operating Activity | 91,411 | 35,992 | 25,432 | 129,909 | 121,073 |
| Operating Cash Flow | $-22,894 | $-37,211 | $-42,194 | $-237,475 | $-201,755 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 171,958 | 70,182 | 53,157 | 200,577 | 271,285 |
| PPE Investments | -375 | -235 | N/A | N/A | -82 |
| Purchase Sale Intangibles | -38,918 | -23,870 | -11,784 | -36,212 | -26,569 |
| Other Investing Activity | -38,852 | -23,807 | -11,867 | -101,252 | -91,569 |
| Investing Cash Flow | $132,731 | $46,140 | $41,290 | $99,325 | $179,634 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,796 | 4,706 | 4,243 | 139,190 | 571 |
| Other Financing Activity | -68,942 | 487 | -525 | 232 | -268 |
| Financing Cash Flow | $-60,146 | $5,193 | $3,718 | $139,422 | $303 |
| Exchange Rate Effect | 2,704 | 2,497 | 548 | -913 | 51 |
| Beginning Cash Position | 58,535 | 58,535 | 58,535 | 58,176 | 58,176 |
| End Cash Position | 110,930 | 75,154 | 61,897 | 58,535 | 36,409 |
| Net Cash Flow | $52,395 | $16,619 | $3,362 | $359 | $-21,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,894 | -37,211 | -42,194 | -237,475 | -201,755 |
| Capital Expenditure | -375 | -235 | N/A | N/A | -82 |
| Free Cash Flow | -23,269 | -37,446 | -42,194 | -237,475 | -201,837 |